Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Primary Care

Journal Scan / Research · July 06, 2024

Effectiveness and Safety of Apixaban vs Rivaroxaban in Older Patients With Atrial Fibrillation

Heart Rhythm


Additional Info

Disclosure statements are available on the authors' profiles:

Heart Rhythm
Comparative Effectiveness and Safety of Apixaban and Rivaroxaban in Older Patients with Atrial Fibrillation: A Population-Based Cohort Study
Heart Rhythm 2024 Jun 13;[EPub Ahead of Print], M Shurrab, PC Austin, CA Jackevicius, K Tu, F Qiu, O Haldenby, A Middleton, MP Turakhia, RD Lopes, WE Boden, LA Castellucci, PA Heidenreich, JS Healey, DT Ko

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading